Clinical Trial On Children

Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.

Pfizer and BioNTech on Monday said clinical trial results showed their coronavirus vaccine was "safe, well tolerated" and produced a "robust" immune response in children aged five to 11, adding that they would seek regulatory approval shortly.

South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.

Hyderabad-based Biological E Limited has been given permission to conduct the phase two/three clinical trial of its indigenously developed COVID-19 vaccine on children and adolescents aged between five and 18 years with certain conditions.

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.

Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research In Delhi.

Prasar Bharati today announced that India has begun the clinical trial of Bharat Biotech's Covaxin on children. The testing is being done at the AIIMS Patna, it said.

A plea to set aside the permission granted by the Drugs Controller General to Bharat Biotech for conducting phase II/III clinical trial of its Covaxin COVID-19 vaccine on the 2-18 age group was heard by the high court which sought Centre's stand.

Covaxin trials on children from two to 18 years were cleared by the Drugs Controller General of India (DCGI) today. This is the first time in India that a Covid vaccine will be tested on children.

US biotech firm Novavax said Monday it had started clinical trials of its proposed Covid-19 vaccine on children, in a program that will involve up to 3,000 adolescents aged 12-17.

Bharat Biotech, which received emergency approval for its Covid-19 vaccine only in "clinical trial mode", is allowed to conduct its trials on children who are above the age of 12 years.

The US government shutdown could block hundreds of cancer patients, including children, from entering last-ditch clinical trials for treatment, US media reported on Wednesday.

Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.

Pfizer and BioNTech on Monday said clinical trial results showed their coronavirus vaccine was "safe, well tolerated" and produced a "robust" immune response in children aged five to 11, adding that they would seek regulatory approval shortly.

South Africa on Friday joined the international Phase 3 clinical trials of China's Sinovac Biotech COVID-19 vaccine for those aged between 6 months and 17 years, with first of the 2,000 children receiving their jabs.

Hyderabad-based Biological E Limited has been given permission to conduct the phase two/three clinical trial of its indigenously developed COVID-19 vaccine on children and adolescents aged between five and 18 years with certain conditions.

Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.

Recruitment of volunteers for the phase 2/3 clinical trial of COVID-19 vaccine Covovax among children aged 2 to 17 years began on Sunday at the Hamdard Institute of Medical Sciences and Research In Delhi.

Prasar Bharati today announced that India has begun the clinical trial of Bharat Biotech's Covaxin on children. The testing is being done at the AIIMS Patna, it said.

A plea to set aside the permission granted by the Drugs Controller General to Bharat Biotech for conducting phase II/III clinical trial of its Covaxin COVID-19 vaccine on the 2-18 age group was heard by the high court which sought Centre's stand.

Covaxin trials on children from two to 18 years were cleared by the Drugs Controller General of India (DCGI) today. This is the first time in India that a Covid vaccine will be tested on children.

US biotech firm Novavax said Monday it had started clinical trials of its proposed Covid-19 vaccine on children, in a program that will involve up to 3,000 adolescents aged 12-17.

Bharat Biotech, which received emergency approval for its Covid-19 vaccine only in "clinical trial mode", is allowed to conduct its trials on children who are above the age of 12 years.

The US government shutdown could block hundreds of cancer patients, including children, from entering last-ditch clinical trials for treatment, US media reported on Wednesday.